Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854431) titled 'CHECK-NIRS2D-Study' on Sept. 28.
Study Type: Observational
Primary Sponsor: Heinrich-Heine University, Duesseldorf
Condition:
NIRS
Tissue Oxygenation
Microvascular Perfusion
Vascular Occlusion Test
Ischemia-reperfusion
Healty Volunteers
Physiological and Behavioral Factors
Temperature
Caffeine
Nicotine
Microcirculation
Protocol Standardization
Recruitment Status: Recruiting
Date of First Enrollment: July 28, 2026
Target Sample Size: 20
Countries of Recruitment:
Germany
To know more, visit https://clinicaltrials.gov/study/NCT07854431
Published by HT Digital Content Services with permission from Health Daily ...